Topics

fragmentarion
StemSocial
Tuesday, April 4, 2023 7:27 AM
Hope for Alzheimer's Patients: Biogen's Latest Drug Reverses Progression of Disease
A new drug from Biogen called BIIB080 has shown promising early results in reducing levels of tau protein, a toxic protein linked to Alzheimer's disease. A Phase Ib trial found that the drug reduced tau
$ 4.089
249
4
mpinvest
deutsch
Wednesday, July 31, 2019 7:50 AM
Aktienanalyse: Biogen ein Kauf?
Liebe Steemians, liebe Anleger und Börsenfreunde, am letzten Wochenende waren wir bei Freunden im Salzburger Land unterwegs und trafen uns am Abend mit weiteren Bekannten am Wallersee. Es stellte sich
$ 0.352
8
7
talkchain
biotech
Sunday, October 21, 2018 10:07 PM
024 - Does BAN2401 Actually Work? Upcoming Subgroup Analyses
Biogen/Eisai to present updated subgroup analyses on their Phase 2 study looking at their Alzheimer's medicine, BAN2401. This antibody binds to amyloid beta protofibrils, reducing plaques in the brain.
$ 0.000
0
crypt0swede
biib
Tuesday, April 10, 2018 3:06 PM
BIIB - BIOGEN REBOUNDING
Biogen could potentially set up here for a rebound higher from very oversold conditions.
$ 0.000
1
johnpark49
healthcare
Thursday, March 8, 2018 10:04 AM
Global Bleeding Disorders Treatment Market Healthcare Status, Industry Analysis and Forecast 2018
A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Bleeding Disorders Treatment Sales Market Research Report (2018-2025)” which provides an outlook of current
$ 0.000
1
Top communities